Literature DB >> 3583822

Immunohistochemical localization of glucagon-like peptide 1. Use of poly- and monoclonal antibodies.

T Kauth, J Metz.   

Abstract

We report the use of poly- and monoclonal antibodies to study the immunohistochemical distribution of glucagon-like peptide-1 immunoreactivity (GLP-1-IR) in various tissues. The polyclonal antibodies against GLP-1 reacted with pancreatic A cells, enteroglucagon (L) cells in the gut, and some neurons in the central nervous system of all species tested. In pancreas and gut the monoclonal antibodies against GLP-1 exhibited a similar, but species specific distribution, relative to the polyclonal antibodies. The colocalization of GLP-1 and glucagon immunoreactivity in pancreatic, intestinal, and nervous tissues is in agreement with previously reported findings that both peptides are part of a single precursor molecule (preproglucagon).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3583822     DOI: 10.1007/bf00500625

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  33 in total

1.  Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain.

Authors:  V K Han; M A Hynes; C Jin; A C Towle; J M Lauder; P K Lund
Journal:  J Neurosci Res       Date:  1986       Impact factor: 4.164

2.  Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences.

Authors:  C Patzelt; E Schiltz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

3.  How glucagon-like is glucagon-like peptide-1?

Authors:  M Ghiglione; L O Uttenthal; S K George; S R Bloom
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

4.  Glucagon and the A cell: physiology and pathophysiology (first two parts).

Authors:  R H Unger; L Orci
Journal:  N Engl J Med       Date:  1981-06-18       Impact factor: 91.245

5.  Demonstration of glucagon in the stomach of human fetuses.

Authors:  M Ravazzola; R H Unger; L Orci
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

6.  Mammalian pancreatic preproglucagon contains three glucagon-related peptides.

Authors:  L C Lopez; M L Frazier; C J Su; A Kumar; G F Saunders
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

8.  Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.

Authors:  N M Hoosein; R S Gurd
Journal:  FEBS Lett       Date:  1984-12-03       Impact factor: 4.124

9.  Hamster preproglucagon contains the sequence of glucagon and two related peptides.

Authors:  G I Bell; R F Santerre; G T Mullenbach
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

10.  Insulin- and glucagonlike peptides in the brain.

Authors:  A Dorn; H G Bernstein; A Rinne; M Ziegler; H J Hahn; S Ansorge
Journal:  Anat Rec       Date:  1983-09
View more
  11 in total

1.  Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.

Authors:  L Scopsi; J Arias; G Houen; G Racchetti; G L Fossati; Y M Galante
Journal:  Histochemistry       Date:  1988

2.  Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell.

Authors:  Samantha K Li; Dan Zhu; Herbert Y Gaisano; Patricia L Brubaker
Journal:  Diabetologia       Date:  2013-12-20       Impact factor: 10.122

3.  Colocalization of glucagon-like peptide and glucagon immunoreactivities in pancreatic islets and intestine of salmonids.

Authors:  M Nozaki; K Miyata; Y Oota; A Gorbman; E M Plisetskaya
Journal:  Cell Tissue Res       Date:  1988-08       Impact factor: 5.249

Review 4.  Glucagon-like peptide-1, a new hormone of the entero-insular axis.

Authors:  C Orskov
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

Review 5.  Intra-islet glucagon-like peptide 1.

Authors:  Genevieve E Fava; Emily W Dong; Hongju Wu
Journal:  J Diabetes Complications       Date:  2016-05-20       Impact factor: 2.852

6.  Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway.

Authors:  Jian-Hui Liu; Fei Yin; Li-Xia Guo; Xiao-Hong Deng; Yin-He Hu
Journal:  Acta Pharmacol Sin       Date:  2009-01-19       Impact factor: 6.150

Review 7.  Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition.

Authors:  Sabrina Jones; Alexia Hyde; Terry L Davidson
Journal:  Nutr Res       Date:  2020-05-13       Impact factor: 3.315

Review 8.  Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.

Authors:  Francis S Willard; Kyle W Sloop
Journal:  Exp Diabetes Res       Date:  2012-05-14

9.  Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior.

Authors:  Sabrina Jones; Shan Luo; Hilary M Dorton; Alexandra G Yunker; Brendan Angelo; Alexis Defendis; John R Monterosso; Kathleen A Page
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

Review 10.  Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?

Authors:  Tito Borner; Ian C Tinsley; Robert P Doyle; Matthew R Hayes; Bart C De Jonghe
Journal:  Br J Pharmacol       Date:  2021-09-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.